Effects of octreotide exposure during pregnancy in acromegaly

Clinical Endocrinology

Volumn 72, Issue 5, 2010, Pages 668-677

  Maffei, Pietro ^a,e   Tamagno, Gianluca ^b   Nardelli, Giovanni Battista ^c   Videau, Catherine ^d   Menegazzo, Carla ^a   Milan, Gabriella ^a   Calcagno, Alessandra ^a   Martini, Chiara ^a   Vettor, Roberto ^a   Epelbaum, Jacques ^d   Sicolo, Nicola ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY OF PARMA   (Italy)

^d INSERM   (France)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR;

ACROMEGALY; ADULT; AMNION FLUID; ANAMNESIS; ARTERY BLOOD FLOW; ARTICLE; BLOOD PLACENTA BARRIER; CASE REPORT; CHILD; CHILD GROWTH; CHILD HEALTH; COLOSTRUM; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FETUS BLOOD; FETUS DEVELOPMENT; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; UTERINE ARTERY;

ACROMEGALY; ADULT; BLOOD FLOW VELOCITY; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; OCTREOTIDE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RECEPTORS, SOMATOSTATIN; UMBILICAL CORD; UTERINE ARTERY;

EID: 77950264418     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03706.x     Document Type: Article

References (32)

1. Caron, P., Gerbeau, C., Pradayrol, L. et al. (1996) Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). Journal of Clinical Endocrinology and Metabolism, 81, 1164 1168.
2. Colao, A., Merola, B., Ferone, D. et al. (1997) Acromegaly. Journal of Clinical Endocrinology and Metabolism, 82, 2777 2781.
3. Herman-Bonert, V., Seliverstov, M. Melmed, S. (1998) Pregnancy in acromegaly: successful therapeutic outcome. Journal of Clinical Endocrinology and Metabolism, 83, 727 731.
4. Cozzi, R., Attanasio, R. Barausse, M. (2006) Pregnancy in acromegaly: a one-center experience. European Journal of Endocrinology, 155, 279 284.
5. Neal, J.M. (2000) Successful pregnancy in a woman with acromegaly treated with octreotide. Endocrine Practice, 6, 148 150.
6. Fassnacht, M., Capeller, B., Arlt, W. et al. (2001) Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clinical Endocrinology, 55, 411 415.
7. Blackhurst, G., Strachan, M.W., Collie, D. et al. (2002) The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clinical Endocrinology, 57, 401 404.
8. Mikhail, N. (2002) Octreotide treatment of acromegaly during pregnancy. Mayo Clinic Proceedings, 77, 297 298.
9. Boulanger, C., Vezzosi, D., Bennet, A. et al. (2004) Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. Journal of Endocrinological Investigation, 27, 465 470.
10. Caron, P., Gerbeau, C. Pradayrol, L. (1995) Maternal-fetal transfer of octreotide. New England Journal of Medicine, 333, 601 602.
11. Landolt, A.M., Schmid, J., Wimpfheimer, C. et al. (1989) Successful pregnancy in a previously infertile woman treated with SMS-201-995 for acromegaly. New England Journal of Medicine, 320, 671 672.
12. Montini, M., Pagani, G., Gianola, D. et al. (1990) Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine. Journal of Endocrinological Investigation, 13, 193.
13. Mozas, J., Ocón, E., López de la Torre, M. et al. (1999) Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. International Journal of Gynaecology and Obstetrics, 65, 71 73.
14. Takeuchi, K., Funakoshi, T., Oomori, S. et al. (1999) Successful pregnancy in an acromegalic woman treated with octreotide. Obstetrics and Gynecology, 93 (Pt 2 848.
15. de Menis, E., Billeci, D., Marton, E. et al. (1999) Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. Journal of Clinical Endocrinology and Metabolism, 84, 1489.
16. Hierl, T., Ziegler, R. Kasperk, C. (2000) Pregnancy in persistent acromegaly. Clinical Endocrinology, 53, 262 263.
17. Serri, O. Lanoie, G. (2003) Successfull pregnancy in a woman with acromegaly treated with octreotide long-acting release. Endocrinologist 13, 17 19.
18. Takano, T., Saito, J., Soyama, A. et al. (2006) Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy. Endocrine Journal, 53, 209 212.
19. Wiesli, P., Zwimpfer, C., Zapf, J. et al. (2006) Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta obstetricia et gynecologica Scandinavica, 85, 900 905.
20. Beckers, A., Stevenaert, A., Foidart, J.M. et al. (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. Journal of Clinical Endocrinology and Metabolism 71, 725 731.
21. Yap, A.S., Clouston, W.M., Mortimer, R.H. et al. (1990) Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy. American Journal of Obstetrics and Gynecology, 163, 477 478.
22. Lunardi, P., Rizzo, A., Missori, P. et al. (1991) Pituitary apoplexy in an acromegalic woman operated on during pregnancy by transphenoidal approach. International Journal of Gynaecology and Obstetrics, 34, 71 74.
23. Braat, D.D., Veersema, S., Assies, J. et al. (1994) Triplet pregnancy after pulsatile gonadotrophin-releasing hormone treatment in an acromegalic woman. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 54, 148 149.
24. Okada, Y., Morimoto, I., Ejima, K. et al. (1997) A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocrine Journal, 44, 117 120.
25. Iwai, H., Ito, H., Ri, S. et al. (2005) Type 1 diabetes associated with asymptomatic acromegaly successfully treated with surgery after pregnancy: a case report. Endocrine Journal, 52, 413 420.
26. Hisano, M., Sakata, M., Watanabe, N. et al. (2006) An acromegalic woman first diagnosed in pregnancy. Archives of Gynecology and Obstetrics, 274, 171 173.
27. Atmaca, A., Dagdelen, S. Erbas, T. (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Experimental and Clinical Endocrinology & Diabetes, 114, 135 139.
28. Guven, S., Durukan, T., Berker, M. et al. (2006) A case of acromegaly in pregnancy: concomitant transsphenoidal adenomectomy and cesarean section. Journal of Maternal-Fetal & Neonatal Medicine, 19, 69 71.
29. Qureshi, A., Kalu, E., Ramanathan, G. et al. (2006) IVF/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. Journal of Assisted Reproduction and Genetics, 23, 439 442.
30. Tsalikian, E., Foley, T.P. Becker, D.J. (1984) Characterization of somatostatin specific binding in plasma cell membranes of human placenta. Pediatric Research, 247, E513 E519.
31. Caron, C., Buscail, L., Beckers, A. et al. (1997) Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. Journal of Clinical Endocrinology and Metabolism, 82, 3771 3776.
32. Shiedermaier, P., Brensing, K.A., Goke, B. et al. (1999) Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers. Digestion, 60, 132 140.